Gara Jalqabaatti › Myeloma Baay’ee › New Jersey › Clifton
Qorannoo klinikaalii Myeloma Baay’ee Clifton, NJ keessatti
Qorannoo 14 Myeloma Baay’ee f Clifton fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Namoota walitti qabaa jiraSadarkaa 4
- Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Hackensack Meridian Health - John Theurer Cancer Center, Hackensack · Miili 7 fagaatti
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- Hackensack Meridian Health, Hackensack · Miili 7 fagaatti
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- John Theurer Cancer Center, Hackensack · Miili 7 fagaatti
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site, Hackensack · Miili 7 fagaatti
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
Mosaic Trial for Stem Cell Transplant Recipients
Namoota walitti qabaa jira
- Hackensack Meridian Health, Nutley · Miili 3 fagaatti
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · Miili 7 fagaatti
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Hackensack · Miili 7 fagaatti
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Hackensack Meridian John Theurer Cancer Center, Hackensack · Miili 7 fagaatti
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- John Theurer Cancer Center at Hackensack UMC, Hackensack · Miili 7 fagaatti
Qorannoo Myeloma Baay’ee magaalota biroo keessatti
- New York City, NYQorannoo 60
- Boston, MAQorannoo 42
- Atlanta, GAQorannoo 42
- Houston, TXQorannoo 38
- Durham, NCQorannoo 37
- Nashville, TNQorannoo 32
- Denver, COQorannoo 27
- Rochester, MNQorannoo 24
- St. Louis, MOQorannoo 24
- Columbus, OHQorannoo 24
- Baldwin Park, CAQorannoo 23
- Edison, NJQorannoo 22
Qorannoo biroo Clifton keessatti
- Kansara Qara'a Non-Small CellQorannoo 24
- Saree (Gosoota Hunda)Qorannoo 15
- Kansara MetastatikiiQorannoo 12
- Leukemia Myeloidii HamaaQorannoo 12
- Saree OljooQorannoo 12
- Kansarii ProstateQorannoo 12
- Kansarii OvariiQorannoo 11
- Dhibee QaraQorannoo 10
- Kansarii ColorectalQorannoo 8
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 8
- Kansa EndometiriyaaliiQorannoo 8
- Cufama OnneeQorannoo 8
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.